Keybanc Maintains Overweight on CryoPort, Raises Price Target to $17

Benzinga Newsdesk www.benzinga.com Positive 79.4%

Neg 0% Neu 0% Pos 79.4%

Keybanc analyst Paul Knight maintains CryoPort (NASDAQ:CYRX) with a Overweight and raises the price target from $15 to $17.